DeKosky ST - Search Results

1

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, LaRossa GN, Spinner ML, Klunk WE, Mathis CA, DeKosky ST, Morris JC, Holtzman DM. Fagan AM, et al. Among authors: dekosky st. Ann Neurol. 2006 Mar;59(3):512-9. doi: 10.1002/ana.20730. Ann Neurol. 2006. PMID: 16372280

2

Imaging technology for neurodegenerative diseases: progress toward detection of specific pathologies.

Mathis CA, Klunk WE, Price JC, DeKosky ST. Mathis CA, et al. Among authors: dekosky st. Arch Neurol. 2005 Feb;62(2):196-200. doi: 10.1001/archneur.62.2.196. Arch Neurol. 2005. PMID: 15710847 Review.

3

Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

Johnson KA, Gregas M, Becker JA, Kinnecom C, Salat DH, Moran EK, Smith EE, Rosand J, Rentz DM, Klunk WE, Mathis CA, Price JC, Dekosky ST, Fischman AJ, Greenberg SM. Johnson KA, et al. Among authors: dekosky st. Ann Neurol. 2007 Sep;62(3):229-34. doi: 10.1002/ana.21164. Ann Neurol. 2007. PMID: 17683091

4

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.

Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, Bi W, Paljug WR, Debnath ML, Hope CE, Isanski BA, Hamilton RL, DeKosky ST. Ikonomovic MD, et al. Among authors: dekosky st. Brain. 2008 Jun;131(Pt 6):1630-45. doi: 10.1093/brain/awn016. Epub 2008 Mar 12. Brain. 2008. PMID: 18339640 Free PMC article.

5

Amyloid imaging in mild cognitive impairment subtypes.

Wolk DA, Price JC, Saxton JA, Snitz BE, James JA, Lopez OL, Aizenstein HJ, Cohen AD, Weissfeld LA, Mathis CA, Klunk WE, De-Kosky ST. Wolk DA, et al. Ann Neurol. 2009 May;65(5):557-68. doi: 10.1002/ana.21598. Ann Neurol. 2009. PMID: 19475670 Free PMC article.

6

Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.

DeKosky ST, Ikonomovic MD, Wang X, Farlow M, Wisniewski S, Lopez OL, Becker JT, Saxton J, Klunk WE, Sweet R, Kaufer DI, Kamboh MI. DeKosky ST, et al. Ann Neurol. 2003 Jan;53(1):81-90. doi: 10.1002/ana.10414. Ann Neurol. 2003. PMID: 12509851

7

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

Price JC, Klunk WE, Lopresti BJ, Lu X, Hoge JA, Ziolko SK, Holt DP, Meltzer CC, DeKosky ST, Mathis CA. Price JC, et al. Among authors: dekosky st. J Cereb Blood Flow Metab. 2005 Nov;25(11):1528-47. doi: 10.1038/sj.jcbfm.9600146. J Cereb Blood Flow Metab. 2005. PMID: 15944649

8

Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.

Lopresti BJ, Klunk WE, Mathis CA, Hoge JA, Ziolko SK, Lu X, Meltzer CC, Schimmel K, Tsopelas ND, DeKosky ST, Price JC. Lopresti BJ, et al. Among authors: dekosky st. J Nucl Med. 2005 Dec;46(12):1959-72. J Nucl Med. 2005. PMID: 16330558 Free article.

9

X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease.

Ikonomovic MD, Abrahamson EE, Isanski BA, Debnath ML, Mathis CA, Dekosky ST, Klunk WE. Ikonomovic MD, et al. Among authors: dekosky st. Methods Enzymol. 2006;412:123-44. doi: 10.1016/S0076-6879(06)12009-1. Methods Enzymol. 2006. PMID: 17046656 Review.

10

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

Klunk WE, Mathis CA, Price JC, Lopresti BJ, DeKosky ST. Klunk WE, et al. Among authors: dekosky st. Brain. 2006 Nov;129(Pt 11):2805-7. doi: 10.1093/brain/awl281. Brain. 2006. PMID: 17071918 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

515 results

Search Page